Related Experiment Video
Updated: Mar 22, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Severe Obesity in Cancer Care
1CancerCare Manitoba, Winnipeg, Canada.
Oncology Nursing Forum
|April 23, 2016
Summary
Obesity impacts cancer screening and staging. Obese women face barriers to breast and cervical screenings, and higher BMIs complicate surgical staging for endometrial cancer.
Area of Science:
- Oncology
- Public Health
- Medical Imaging
Background:
- Obesity is a growing global health concern with significant implications for cancer care.
- Excess body fat and increased body mass index (BMI) can impede cancer detection, diagnosis, and treatment.
- Specific challenges exist in screening and staging for gynecological cancers in obese individuals.
Purpose of the Study:
- To investigate the impact of obesity on cancer screening participation and diagnostic procedures.
- To examine the relationship between high BMI and the completeness of surgical staging for endometrial cancer.
- To identify barriers contributing to the underuse of cancer screening and adequate staging in obese patients.
Main Methods:
- Retrospective review of 324 primary surgical patients.
- Analysis of screening practices and surgical staging completion rates stratified by BMI.
- Qualitative assessment of barriers to care, including patient and provider factors.
Main Results:
- Obese women show reduced engagement in breast and cervical cancer screenings.
- Patients with a BMI > 35 kg/m2 experience difficulties with physical and internal pelvic examinations.
- Individuals with a BMI > 40 kg/m2 were seven times less likely to complete surgical staging for endometrial cancer.
Conclusions:
- Obesity presents significant challenges to effective cancer screening and staging, particularly for gynecological cancers.
- Healthcare provider bias and patient-related factors (embarrassment, fear) create substantial barriers to addressing obesity in clinical settings.
- Improved strategies are needed to overcome these obstacles and ensure equitable cancer care for obese individuals.
Related Concept Videos
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
334
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
274
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
274
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
363
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
363
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Chronic Pancreatitis II: Collaborative Care
467
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
467
